Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Attention Deficit Disorder with Hyperactivity | 7 | 2019 | 189 | 2.930 |
Why?
|
| Iron | 5 | 2019 | 197 | 2.430 |
Why?
|
| Neuroimaging | 2 | 2018 | 122 | 1.150 |
Why?
|
| Brain | 5 | 2019 | 2175 | 1.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2018 | 237 | 1.020 |
Why?
|
| Central Nervous System Stimulants | 2 | 2019 | 221 | 1.020 |
Why?
|
| Brain Mapping | 5 | 2018 | 531 | 0.720 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2019 | 2222 | 0.660 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2018 | 239 | 0.640 |
Why?
|
| Neural Pathways | 1 | 2018 | 323 | 0.540 |
Why?
|
| Cocaine-Related Disorders | 1 | 2018 | 504 | 0.460 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 119 | 0.430 |
Why?
|
| Cerebral Cortex | 2 | 2013 | 415 | 0.430 |
Why?
|
| Algorithms | 4 | 2022 | 1194 | 0.390 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 346 | 0.380 |
Why?
|
| Child | 6 | 2019 | 6400 | 0.340 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 1241 | 0.300 |
Why?
|
| Aging | 2 | 2014 | 911 | 0.290 |
Why?
|
| Adolescent | 7 | 2019 | 8903 | 0.240 |
Why?
|
| Models, Neurological | 2 | 2014 | 136 | 0.230 |
Why?
|
| White Matter | 3 | 2014 | 174 | 0.220 |
Why?
|
| Humans | 15 | 2022 | 68525 | 0.210 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2013 | 211 | 0.210 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 64 | 0.190 |
Why?
|
| Biomarkers, Tumor | 2 | 2022 | 508 | 0.190 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2021 | 146 | 0.190 |
Why?
|
| Esophageal Neoplasms | 1 | 2021 | 150 | 0.180 |
Why?
|
| Male | 10 | 2021 | 37281 | 0.180 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 300 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 689 | 0.170 |
Why?
|
| Biomarkers | 2 | 2015 | 1593 | 0.170 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 475 | 0.160 |
Why?
|
| Psychopathology | 1 | 2017 | 29 | 0.150 |
Why?
|
| Echo-Planar Imaging | 2 | 2014 | 17 | 0.140 |
Why?
|
| Female | 9 | 2021 | 38015 | 0.140 |
Why?
|
| Anisotropy | 2 | 2013 | 105 | 0.140 |
Why?
|
| Connectome | 1 | 2018 | 91 | 0.140 |
Why?
|
| Gray Matter | 2 | 2013 | 57 | 0.140 |
Why?
|
| Underage Drinking | 1 | 2016 | 25 | 0.140 |
Why?
|
| Free Radical Scavengers | 1 | 2016 | 112 | 0.140 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2014 | 49 | 0.130 |
Why?
|
| Image Enhancement | 2 | 2012 | 143 | 0.120 |
Why?
|
| Multimodal Imaging | 1 | 2014 | 62 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 1172 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 2016 | 296 | 0.110 |
Why?
|
| Marijuana Abuse | 1 | 2016 | 251 | 0.110 |
Why?
|
| Magnetic Fields | 1 | 2012 | 21 | 0.110 |
Why?
|
| Tissue Distribution | 1 | 2012 | 282 | 0.100 |
Why?
|
| Prognosis | 1 | 2017 | 2093 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 333 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2012 | 219 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2021 | 3702 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2013 | 782 | 0.100 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 1753 | 0.100 |
Why?
|
| Adult | 4 | 2021 | 21375 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2017 | 2004 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1548 | 0.090 |
Why?
|
| Frontal Lobe | 1 | 2011 | 156 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2077 | 0.090 |
Why?
|
| Comorbidity | 1 | 2013 | 1425 | 0.080 |
Why?
|
| Age Factors | 1 | 2013 | 1860 | 0.080 |
Why?
|
| Internal Capsule | 2 | 2014 | 7 | 0.060 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 30 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2021 | 58 | 0.050 |
Why?
|
| Esophagogastric Junction | 1 | 2021 | 118 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2021 | 201 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 211 | 0.050 |
Why?
|
| Wnt Signaling Pathway | 1 | 2021 | 57 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 186 | 0.050 |
Why?
|
| Young Adult | 1 | 2012 | 5708 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2014 | 2453 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 467 | 0.040 |
Why?
|
| Infant | 2 | 2014 | 2891 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2021 | 1663 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 756 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 1849 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 7264 | 0.030 |
Why?
|
| Neurites | 1 | 2014 | 18 | 0.030 |
Why?
|
| Corpus Callosum | 1 | 2014 | 29 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2014 | 115 | 0.030 |
Why?
|
| External Capsule | 1 | 2013 | 3 | 0.030 |
Why?
|
| Axons | 1 | 2014 | 139 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2014 | 705 | 0.020 |
Why?
|
| Atlases as Topic | 1 | 2007 | 5 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 438 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2007 | 55 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2007 | 105 | 0.020 |
Why?
|
| Observer Variation | 1 | 2007 | 330 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 579 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 3185 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 1341 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 7028 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2007 | 446 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 21119 | 0.010 |
Why?
|